Welcome to our dedicated page for Paysign SEC filings (Ticker: PAYS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Paysign, Inc. filings document formal disclosures for a Nevada public company providing patient affordability programs, donor compensation solutions, engagement and management platforms, and integrated payment processing. Recent Form 8-K reports furnish operating results and financial-condition updates tied to quarterly and annual earnings releases.
The company’s proxy materials describe annual meeting matters, director elections, auditor ratification, board and committee responsibilities, executive compensation, and beneficial ownership of Paysign securities. Other current reports include Regulation FD disclosures related to stockholder derivative action settlement materials, giving the filing record governance, litigation, ownership and reporting-context coverage in addition to financial results.
Paysign, Inc. Chief Financial Officer Jeffery Bradford Baker exercised a stock grant covering 64,000 shares of common stock on July 31, 2026. The vesting comes from restricted stock that vests in equal annual installments through July 31, 2027, and 28,506 shares were withheld to satisfy related tax obligations at $8.96 per share.
Paysign, Inc. Chief Payments Officer Matthew Louis Lanford reported the vesting and exercise of 64,000 shares of restricted stock into common stock on July 31, 2026. Footnotes state this award vests in equal annual installments from July 31, 2022 through July 31, 2027. On the same date, 25,185 shares of common stock were withheld at $8.96 per share to satisfy associated tax withholding obligations.
Triplett Dennis L reported acquisition or exercise transactions in this Form 4 filing.
Paysign, Inc. director Dennis L. Triplett reported a compensation-related equity award. On May 8, 2026, he received a grant of 20,000 shares of Common Stock, with these shares scheduled to vest on May 8, 2027. Following this award, his directly held Common Stock position is 270,000 shares.
NEWMAN JEFFREY B reported acquisition or exercise transactions in this Form 4 filing.
Paysign, Inc. director Jeffrey B. Newman received a grant of 20,000 shares of common stock on May 8, 2026. These shares vest on May 8, 2027. Following the award, he directly holds 70,000 Paysign common shares.
Paysign, Inc. director Bruce A. Mina reported one equity award and two share sales. On May 8, 2026, Mina received a grant of 20,000 shares of common stock at $0.00 per share, scheduled to vest on May 8, 2027. He then sold 10,000 shares on June 1, 2026 at $7.10 per share and another 10,000 shares on June 11, 2026 at $7.095 per share in open market or private transactions. The filing’s Rule 10b5-1 checkbox is not marked as being under a trading plan.
HENRY DANIEL R reported acquisition or exercise transactions in this Form 4 filing.
Paysign, Inc. director and reporting person HENRY DANIEL R received a grant of 20,000 shares of common stock on May 8, 2026. These shares vest on May 8, 2027. Following the grant, he holds 149,884.198 shares of Paysign common stock in direct ownership.
Paysign, Inc. director, CEO and 10% owner Mark Newcomer reported selling 50,000 shares of Common Stock on July 29, 2026 at a weighted average price of $9.3797 per share, in trades ranging from $9.3720 to $9.39. The sale was effected under a Rule 10b5-1 trading plan adopted on September 12, 2025, leaving 9,222,027 shares held directly.
BlackRock, Inc. reports beneficial ownership of common stock of PaySign, Inc. on a Schedule 13G. BlackRock reports beneficial ownership of 3,030,447 shares of PaySign common stock, representing 5.4% of the class as of the filing.
BlackRock has sole voting power over 2,985,903 shares and sole dispositive power over 3,030,447 shares, with no shared voting or dispositive power. Various underlying persons may receive dividends or sale proceeds, but no single person has an interest in more than five percent of the outstanding common shares.
Paysign, Inc. EVP of Operations and director Joan M Herman reported open-market sales of a total of 59,904 shares of common stock on July 15–16, 2026, at weighted average prices of $8.5962 and $8.6932 per share. Following these transactions, Herman holds 647,105 shares directly. The sales were effected under a Rule 10b5-1 trading plan adopted on September 12, 2025.
Paysign, Inc. executive vice president of operations Joan M. Herman reported an open-market sale of 100,000 shares of common stock at a weighted average price of $8.0114 per share. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 12, 2025.
After this sale, Herman directly holds 707,009 shares of Paysign common stock. Because the sale occurred pursuant to a Rule 10b5-1 plan, it appears to be part of a scheduled diversification or liquidity program rather than a discretionary one-time trade.